COVID Impact
COVID-19 pandemic and Changes in Breast Cancer Management in the UK
July 2020
Summary
What were the changes to clinical practice compared to before COVID-19 pandemic in breast cancer looking at surgery, radiotherapy, and systemic therapies in the UK.
What were the general principles and triage for treating HR+ ABC patients during COVID pandemic
What were the post COVID-19 planning in terms of data collection
Highlights
- 1
How to provide the usual standard of care during COVID19 pandemic with unprecedented strain on Health System in the UK
- 2
What were the changes in Clinical Practice?
- 3
Which activities stopped immediately (research trials, breast cancer screening)

Professor John Robertson
Head of Division of Breast Surgery. Director ...
Derby, UK
Dr. John Robertson is Professor of Surgery at the University of Nottingham and a Consultant Surgeon at the University Hospitals of Derby & Burton, UK.
Comments (0)